Gagnon Securities’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $38.7K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $43K | Sell |
|
|||||
|
2024
Q1 | $62.7K | Buy |
|
|||||
|
2023
Q4 | $131K | Buy |
|
|||||
|
2023
Q3 | $24.5K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $46.6K | Sell |
|
|||||
|
2022
Q3 | $194K | Buy |
|
|||||
|
2022
Q2 | $327K | Buy |
|
|||||
|
2022
Q1 | $926K | Buy |
|
|||||
|
2021
Q4 | $821K | Sell |
|
|||||
|
2021
Q3 | $1.8M | Buy |
|
|||||
|
2021
Q2 | $2.36M | Buy |
|
|||||
|
2021
Q1 | $2.43M | Buy |
|
|||||
|
2020
Q4 | $2.27M | Buy |
|
|||||
|
2020
Q3 | $2.43M | Buy |
|
|||||
|
2020
Q2 | $1.41M | Buy |
|
|||||
|
2020
Q1 | $449K | Sell |
|
|||||
|
2019
Q4 | $683K | Buy |
|